These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1624295)

  • 21. [Epidermal growth factor receptor gene amplification and E-cadherin expression in head and neck carcinomas].
    Rodrigo Tapia JP; Domínguez Iglesias F; Alvarez Marcos C; González Meana MV; García Pedrero J; Suárez Nieto C
    Acta Otorrinolaringol Esp; 2004 Dec; 55(10):482-7. PubMed ID: 15658558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
    Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
    BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer.
    Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi VD; Deo MG
    Eur J Cancer B Oral Oncol; 1992 Oct; 28B(2):139-43. PubMed ID: 1306731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGFR amplification and expression in oral squamous cell carcinoma in young adults.
    Costa V; Kowalski LP; Coutinho-Camillo CM; Begnami MD; Calsavara VF; Neves JI; Kaminagakura E
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):817-823. PubMed ID: 29395668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene.
    Ishikawa J; Maeda S; Sugiyama T; Nishimura R; Mizoguchi A; Kamidono S
    Int J Cancer; 1989 Dec; 44(6):1000-4. PubMed ID: 2606569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
    Suzuki S; Ishikawa K
    Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines.
    Yamamoto T; Kamata N; Kawano H; Shimizu S; Kuroki T; Toyoshima K; Rikimaru K; Nomura N; Ishizaki R; Pastan I
    Cancer Res; 1986 Jan; 46(1):414-6. PubMed ID: 2998610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.
    O-Charoenrat P; Rhys-Evans P; Modjtahedi H; Court W; Box G; Eccles S
    Int J Cancer; 2000 May; 86(3):307-17. PubMed ID: 10760816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification.
    Itakura Y; Sasano H; Shiga C; Furukawa Y; Shiga K; Mori S; Nagura H
    Cancer; 1994 Aug; 74(3):795-804. PubMed ID: 8039107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma.
    Blackwell JL; Miller CR; Douglas JT; Li H; Reynolds PN; Carroll WR; Peters GE; Strong TV; Curiel DT
    Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):856-63. PubMed ID: 10448731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted molecular therapy for oral cancer with epidermal growth factor receptor blockade: a preliminary report.
    Myers JN; Holsinger FC; Bekele BN; Li E; Jasser SA; Killion JJ; Fidler IJ
    Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):875-9. PubMed ID: 12162763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
    Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition.
    Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Okamoto K; Calderwood SK; Kozaki KI
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1267-1272. PubMed ID: 30017201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
    Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
    Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.
    Tan DSW; Chong FT; Leong HS; Toh SY; Lau DP; Kwang XL; Zhang X; Sundaram GM; Tan GS; Chang MM; Chua BT; Lim WT; Tan EH; Ang MK; Lim TKH; Sampath P; Chowbay B; Skanderup AJ; DasGupta R; Iyer NG
    Nat Med; 2017 Oct; 23(10):1167-1175. PubMed ID: 28920960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of EGF receptor levels in human tumor cells transfected with an antisense RNA expression vector.
    Yamada H; Koizumi S; Kimura M; Shimizu N
    Exp Cell Res; 1989 Sep; 184(1):90-8. PubMed ID: 2477267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of human epidermal growth factor and its receptor in esophageal cancer.
    Mukaida H; Yamamoto T; Hirai T; Toi M; Nakamura T; Wada T; Yamashita Y; Kawano K; Niimoto M
    Jpn J Surg; 1990 May; 20(3):275-82. PubMed ID: 2193179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.